RT-based combination therapy for brain metastasis from NSCLC with non-EGFR mutation/ALK gene rearrangement: A network meta-analysis

Overview of attention for article published in Frontiers in oncology, November 2022

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (54th percentile)
Good Attention Score compared to outputs of the same age and source (77th percentile)

Mentioned by

twitter: 4 X users

Readers on

mendeley: 4 Mendeley

Summary X

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 27,852 followers.

RT-based combination therapy for brain metastasis from NSCLC with non-EGFR mutation/ALK gene rearrangement: A network meta-analysis https://t.co/TIFtx0lYRH

15 Dec 2022

Reply Repost Favourite

RT-based combination therapy for brain metastasis from NSCLC with non-EGFR mutation/ALK gene rearrangement: A network meta-analysis #lymphoma #lymsm https://t.co/EcRefzWxBg

15 Dec 2022

Reply Repost Favourite

RT-based combination therapy for brain metastasis from NSCLC with non-EGFR mutation/ALK gene rearrangement: A network meta-analysis https://t.co/4R3Xg8mYPC https://t.co/LlzARoBNw6

29 Nov 2022

Reply Repost Favourite

New research: RT-based combination therapy for brain metastasis from NSCLC with non-EGFR mutation/ALK gene rearrangement: A network meta-analysis: Introduction Radiotherapy (RT) is currently the main treatment for brain metastases (BMs) from… https://t.co

28 Nov 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.